Bentong Yu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Surgery top 5%
- Esophageal Cancer Research and Treatment
- Esophageal and GI Pathology
Papers in
- Surgery 13
- Esophageal Cancer Research and Treatment 10
-
- Lung Cancer Diagnosis and Treatment 6
- Co-authors
- Hezhong Chen (6 shared papers)Jianbin Wang (6 shared papers)Tianyu Han (6 shared papers)Mingxi Gan (6 shared papers)Zhigang Li (6 shared papers)Yifeng Sun (3 shared papers)Baoquan Song (1 shared paper)Lijie Tan (4 shared papers)
- Journals
- BioMed Research International (2 papers)Epigenomics (2 papers)Annals of Oncology (2 papers)Autophagy (2 papers)Oncology Reports (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Bentong Yu
55 papers receiving 1.4k citations
Bentong Yu's Hit Papers
Peers
Comparison fields: 5 of 82
- Cancer Research 197
- Surgery 463
- Pulmonary and Respiratory Medicine 286
- Oncology 214
- Immunology 141
Countries citing papers authored by Bentong Yu
This map shows the geographic impact of Bentong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bentong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bentong Yu more than expected).
Fields of papers citing papers by Bentong Yu
This network shows the impact of papers produced by Bentong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bentong Yu. The network helps show where Bentong Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bentong Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma Hit paper breakdown → | 2022 | 175 |
| 2 | 2021 | 121 | |
| 3 | 2018 | 91 | |
| 4 | 2022 | 73 | |
| 5 | 2023 | 67 | |
| 6 | 2022 | 56 | |
| 7 | 2018 | 51 | |
| 8 | 2007 | 50 | |
| 9 | 2013 | 41 | |
| 10 | 2020 | 40 | |
| 11 | 2023 | 35 | |
| 12 | 2021 | 35 | |
| 13 | 2020 | 31 | |
| 14 | 2023 | 31 | |
| 15 | 2021 | 30 | |
| 16 | 2020 | 30 | |
| 17 | 2022 | 26 | |
| 18 | 2018 | 26 | |
| 19 | GRHL2 suppresses tumor metastasis via regulation of transcriptional activity of RhoG in non-small cell lung cancer. | 2017 | 25 |
| 20 | 2018 | 25 |
About Bentong Yu
Bentong Yu is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Oncology, having authored 57 papers that have together received 1.4k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (10 papers), RNA modifications and cancer (7 papers), Autophagy in Disease and Therapy (6 papers), Cancer-related molecular mechanisms research (6 papers), Lung Cancer Diagnosis and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Research Studies (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Cancer Research (197 citations), Surgery (463 citations), Pulmonary and Respiratory Medicine (286 citations), Oncology (214 citations) and Immunology (141 citations). Bentong Yu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Hezhong Chen, Jianbin Wang, Tianyu Han, Mingxi Gan, Zhigang Li, Yifeng Sun, Baoquan Song, Lijie Tan, Yang Yang and Xufeng Guo. Their work appears in journals such as BioMed Research International, Epigenomics, Annals of Oncology, Autophagy and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.